Why Sorrento And Infinity Are Moving Today

Sorrento Therapeutics SRNE shares are trading higher on Wednesday after the company announced it has received CLIA Licensure from the State of California that permits testing of clinical samples.

Sorrento Therapeutics is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.

Sorrento Therapeutics shares were trading up 4.81% at $8.28 at the time of publication. The stock has a 52-week high of $19.39 and a 52-week low of $1.55.

Infinity Pharmaceuticals INFI shares are trading lower after the company announced the presentation of front-line triple-negative breast cancer data from its ongoing Phase 2 Mario-3 trial at the 2020 San Antonio Breast Cancer Symposium.

Infinity Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development.

Infinity Pharmaceuticals shares were trading down 17.15% at $2.30. The stock has a 52-week high of $3.13 and a 52-week low of 60 cents.